Seeger Weiss LLP Welcomes Stephan J. Mallenbaum as Executive Director

Seeger Weiss LLP announced today that Stephan J. Mallenbaum has joined the firm as its new Executive Director. Stephan is an experienced law firm leader, with a track record of innovation in legal services and a deep knowledge of law firm operations.  Stephan has served in senior management and practice leadership roles at some of […]

November 27, 2018

Stephan J. Mallenbaum

Seeger Weiss LLP announced today that Stephan J. Mallenbaum has joined the firm as its new Executive Director.

Stephan is an experienced law firm leader, with a track record of innovation in legal services and a deep knowledge of law firm operations.  Stephan has served in senior management and practice leadership roles at some of the largest and most prestigious global law firms.

As an accomplished lawyer and strategic business advisor, Stephan brings over 30 years of experience in the legal industry to his new position overseeing Seeger Weiss’ financial and business operations.  Stephan will also play a key role in the strategic growth of the firm.

“I’m excited to join the Seeger Weiss team,” Stephan said. “The Firm has achieved impressive national impact, and has delivered exceptional client service, at a time of unique challenges in the legal industry.  I look forward to helping the Firm continue to build on its extraordinary success.”

Co-Managing Partner Stephen Weiss commented, “We are likewise excited to have Stephan on board. He’s an outstanding addition to the firm, bringing a wealth of knowledge and experience that will help us further refine our client services, as well as manage our firm’s brand-new facility and operations.”

A native New Yorker, Stephan received his B.S. degree from the Sloan School of Management at MIT and his J.D. from Cornell Law School.

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More